ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselCORETAG Therapeutics AG
CORETAG Therapeutics AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Coretag is the development of therapeutics for the treatment of cancer, particularly through the development of platforms for targeted tumor treatment. The company focuses on developing innovative solutions to improve treatment outcomes and the quality of life for cancer patients.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

CORETAG Therapeutics AG

Pharmaceutical Industry
✓ Offered2
Tumor necrosis targeting platform
Platform for targeted engagement of tumor necroses to uncover hidden cancer cells and improve treatment outcomes for cancer patients.
Pipeline for oncology drug programmes
Pipeline with development projects around NC-Scan, CyanTag, CyanCore and HQ4 in the field of targeted cancer treatment.
Trust & reputation

ranQ Trust Score of CORETAG Therapeutics AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

CORETAG Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
CORETAG Therapeutics AG scores 72.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
CORETAG Therapeutics AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
CORETAG Therapeutics AG scores 1.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.1.74%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

CORETAG Therapeutics AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once CORETAG Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

CORETAG Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank CORETAG Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of CORETAG Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 18
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-251.041.677
Founded
2020 · 6 years
Last commercial register change
December 10, 2024
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RS
    Regeneron Switzerland GmbH
    Basel
    MS
    Moderna Switzerland GmbH
    Basel
    LT
    LifeMine Therapeutics (Switzerland) GmbH
    Basel
    ST
    SHRARE Technology AG
    Basel
    FT
    FoRx Therapeutics AG
    Basel
    GA
    Galvita AG
    Basel
    AA
    ARTIDIS AG
    Basel
    NA
    NBE-Therapeutics AG
    Basel